These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 14732949)

  • 41. Microalbuminuria: is it a valid predictor of cardiovascular risk?
    Tagle R; Acevedo M; Vidt DG
    Cleve Clin J Med; 2003 Mar; 70(3):255-61. PubMed ID: 12678217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16.
    Yokoyama H; Oishi M; Kawai K; Sone H;
    Diabet Med; 2008 Dec; 25(12):1426-32. PubMed ID: 19046241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microalbuminuria in a diabetic population.
    Mills G; Hocken AG
    N Z Med J; 1986 Jan; 99(794):17-9. PubMed ID: 3080714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 46. Exercise induced proteinuria is an early indicator of diabetic nephropathy.
    Jauhari J
    J Assoc Physicians India; 1999 Nov; 47(11):1127-8. PubMed ID: 10862339
    [No Abstract]   [Full Text] [Related]  

  • 47. [Specifics of diabetic nephropathy, viewpoint in diabetology: trends of diabetic nephropathy in diabetes].
    Krempf M
    Nephrol Ther; 2006 May; 2 Suppl 3():S190-2. PubMed ID: 17370849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [How to defuse the diabetes mellitus time bomb: identify early signs and vascular injuries, minimize risk factors].
    Janka HU
    MMW Fortschr Med; 2003 May; 145(21):29-30. PubMed ID: 12845863
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of microalbuminuria testing in persons with type 2 diabetes: are the right patients being tested?
    Hueston WJ; Scibelli S; Mainous AG
    J Fam Pract; 2001 Aug; 50(8):669-73. PubMed ID: 11509159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Microalbuminuria in patients with type 2 diabetes mellitus in general practice].
    Ubink-Veltmaat LJ; Bilo HJ; Meyboom-de Jong B
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2026-30. PubMed ID: 15554000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronic renal disease in diabetic and prediabetic subjects: a community-based study in Shanghai].
    Wang WX; Jia WP; Bao YQ; Lu JX; Lu HJ; Zuo YH; Du J; Liu LH; Fang R; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2527-32. PubMed ID: 17198559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Microalbuminuria in diabetes: setting the points for treatment].
    Lehnert H; Klose S; Lobmann R; Zehnder D
    MMW Fortschr Med; 2006 May; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interest of Clinitek Microalbumin in screening for microalbuminuria: results of a multicentre study in 302 diabetic patients.
    Le Floch JP; Marre M; Rodier M; Passa P
    Diabetes Metab; 2001 Feb; 27(1):36-9. PubMed ID: 11240444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
    Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial.
    Cortés-Sanabria L; Cabrera-Pivaral CE; Cueto-Manzano AM; Rojas-Campos E; Barragán G; Hernández-Anaya M; Martínez-Ramírez HR
    Am J Kidney Dis; 2008 May; 51(5):777-88. PubMed ID: 18436088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diabetic nephropathy--screening, follow-up and treatment. Nephropathy Study Groups of The Finnish Diabetes Organization].
    Koivisto V; Groop PH; Huttunen NP; Kivekäs J; Pasternack A; Uusitupa M; Viikari J
    Nord Med; 1997 May; 112(5):154-62. PubMed ID: 9273505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The lack of screening for diabetic nephropathy: evidence from a privately insured population.
    Mainous AG; Gill JM
    Fam Med; 2001 Feb; 33(2):115-9. PubMed ID: 11271738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapy of kidney failure in diabetes mellitus].
    Girndt J; Scheler F
    Med Klin; 1979 Dec; 74(49):1871-5. PubMed ID: 392295
    [No Abstract]   [Full Text] [Related]  

  • 60. [The significance of diagnosing microalbuminuria and microglobulinuria in diabetes mellitus and arterial hypertension].
    Kasprowicz B; Jaremin B; Górski J
    Przegl Lek; 1997; 54(3):180-4. PubMed ID: 9297195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.